• Thurs news: Lilly’s weight-loss drug prevents diabetes. Merck pays $588M for bispecific. Amgen speaks out about bone density issues with obesity drug. PTC gets gene therapy approval. JNJ’s 340B legal fight. See more on our front page


One Ms really?

Quote




















Seems it was the 11th but could be pushed bc due to some other VP/internal person not on board so either way we have 1 or 2 weeks before the news comes. Also, hearing it won’t be as massive as people are thinking/rumored.
 




anonymous said:
Seems it was the 11th but could be pushed bc due to some other VP/internal person not on board so either way we have 1 or 2 weeks before the news comes. Also, hearing it won’t be as massive as people are thinking/rumored.
Click to expand...

Looks like between 30-40 SS to be released total from both sides. Most ABL's have an idea who is on the hit list. Maybe they can give you a hint but they are under strict silence orders for legal reasons.
 








anonymous said:
Looks like between 30-40 SS to be released total from both sides. Most ABL's have an idea who is on the hit list. Maybe they can give you a hint but they are under strict silence orders for legal reasons.
Click to expand...

My ABL told me I was safe. He said it's a lot cuts more than he thought. The package will be very good. Same as the Aimovig reps. 30-40 from both sides seems right.
 
















































Top Bottom
Back
Quote